Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEAT trial of intravenous paracetamol in febrile ICU patients with known or suspected infection
ACTRN12611000981921Phase 3Active, not recruiting
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Infection comparing Intravenous paracetamol with Placebo (2 arms). Primary endpoint: Alive ICU-free days. Started Mar 2012; status: active, not recruiting.
02
Drugs
acetaminophen
03
Conditions
Infection
Beyond the preview
Go deeper on ACTRN12611000981921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000981921.